{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:39:09Z","timestamp":1791135549586,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T00:00:00Z","timestamp":1252627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10096-009-0806-5","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T05:15:08Z","timestamp":1252559708000},"page":"1465-1470","source":"Crossref","is-referenced-by-count":60,"title":["Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection"],"prefix":"10.1007","volume":"28","author":[{"given":"G.","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Garofoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cusato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bollani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Regazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stronati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,11]]},"reference":[{"key":"806_CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17:355\u2013363","journal-title":"Rev Med Virol"},{"key":"806_CR2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14787210.5.3.441","volume":"5","author":"MG Michaels","year":"2007","unstructured":"Michaels MG (2007) Treatment of congenital cytomegalovirus: where are we now? Expert Rev Anti Infect Ther 5:441\u2013448","journal-title":"Expert Rev Anti Infect Ther"},{"key":"806_CR3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11940-008-0020-2","volume":"10","author":"MR Schleiss","year":"2008","unstructured":"Schleiss MR (2008) Congenital cytomegalovirus infection: update on management strategies. Curr Treat Options Neurol 10:186\u2013192","journal-title":"Curr Treat Options Neurol"},{"key":"806_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semperi.2007.01.002","volume":"31","author":"SP Adler","year":"2007","unstructured":"Adler SP, Nigro G, Pereira L (2007) Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin Perinatol 31:10\u201318","journal-title":"Semin Perinatol"},{"key":"806_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253\u2013276","journal-title":"Rev Med Virol"},{"key":"806_CR6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","volume":"143","author":"DW Kimberlin","year":"2003","unstructured":"Kimberlin DW, Lin CY, Sanchez P et al (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomised, controlled trial. J Pediatr 143:16\u201325","journal-title":"J Pediatr"},{"key":"806_CR7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jpeds.2005.01.059","volume":"146","author":"SB Boppana","year":"2005","unstructured":"Boppana SB, Fowler KB, Pass RF et al (2005) Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817\u2013823","journal-title":"J Pediatr"},{"key":"806_CR8","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JCM.41.9.4494-4495.2003","volume":"41","author":"G Gerna","year":"2003","unstructured":"Gerna G, Baldanti F, Percivalle E et al (2003) Early identification of human cytomegalovirus strains by the shell vial assay is prevented by a novel amino acid substitution in UL123 IE1 gene product. J Clin Microbiol 41:4494\u20134495","journal-title":"J Clin Microbiol"},{"key":"806_CR9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jmv.21243","volume":"80","author":"MG Revello","year":"2008","unstructured":"Revello MG, Campanini G, Piralla A et al (2008) Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their family. J Med Virol 80:1415\u20131425","journal-title":"J Med Virol"},{"key":"806_CR10","unstructured":"Lombardi G, Di Comite A, Decembrino L et al (2007) Valganciclovir treatment of newborns with symptomatic congenital cytomegalovirus (CMV) infection. 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, 9\u201314 September, Nice, France"},{"key":"806_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.inf.0000116760.16582.a9","volume":"23","author":"M Burri","year":"2004","unstructured":"Burri M, Wiltshire H, Kahlert C et al (2004) Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl. Pediatr Infect Dis J 23:263\u2013266","journal-title":"Pediatr Infect Dis J"},{"key":"806_CR12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0731-7085(99)00161-2","volume":"21","author":"F Chu","year":"1999","unstructured":"Chu F, Kiang CH, Sung ML et al (1999) A rapid, sensitive HPLC method for the determination of canciclovir in human plasma and serum. J Pharm Biomed Anal 21:657\u2013667","journal-title":"J Pharm Biomed Anal"},{"key":"806_CR13","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/ajhp\/59.13.1267","volume":"59","author":"NH Anaizi","year":"2002","unstructured":"Anaizi NH, Dentinger PJ, Swenson CF (2002) Stability of valganciclovir in extemporaneously compounded oral liquid. Am J Health Syst Pharm 59:1267\u20131270","journal-title":"Am J Health Syst Pharm"},{"key":"806_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ajhp\/60.7.687","volume":"60","author":"CC Henkin","year":"2003","unstructured":"Henkin CC, Grenor JC, Ten Eick AP (2003) Stability of valganciclovir in extemporaneously compounded liquid formulations. Am J Health Syst Pharm 60:687\u2013690","journal-title":"Am J Health Syst Pharm"},{"key":"806_CR15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2165\/00003495-200161080-00013","volume":"61","author":"M Curran","year":"2001","unstructured":"Curran M, Noble S (2001) Valganciclovir. Drugs 61:1145\u20131150","journal-title":"Drugs"},{"key":"806_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00431-006-0109-0","volume":"165","author":"S Schulzke","year":"2006","unstructured":"Schulzke S, Buhrer C (2006) Valganciclovir for treatment of congenital cytomegalovirus infections. Eur J Pediatr 165:575\u2013576","journal-title":"Eur J Pediatr"},{"key":"806_CR17","first-page":"364","volume":"33","author":"CFM Jansen","year":"2005","unstructured":"Jansen CFM, Toet MC, Rademaker CMA et al (2005) Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J Perinat Med 33:364\u2013366","journal-title":"J Perinat Med"},{"key":"806_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.inf.0000261111.90075.4d","volume":"26","author":"L Galli","year":"2007","unstructured":"Galli L, Novelli A, Chiappini E et al (2007) Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants. Pediatr Infect Dis J 26:451\u2013453","journal-title":"Pediatr Infect Dis J"},{"key":"806_CR19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/528376","volume":"197","author":"DW Kimberlin","year":"2008","unstructured":"Kimberlin DW, Acosta EP, Sanchez PJ et al (2008) Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 197:836\u2013845","journal-title":"J Infect Dis"},{"key":"806_CR20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.clpt.6100150","volume":"81","author":"EP Acosta","year":"2007","unstructured":"Acosta EP, Brundage RC, King JR et al (2007) Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of liquid valganciclovir formulation. Clin Pharmacol Ther 81:867\u2013872","journal-title":"Clin Pharmacol Ther"},{"key":"806_CR21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1542\/peds.2005-0629","volume":"117","author":"M Lanari","year":"2006","unstructured":"Lanari M, Lazzarotto T, Venturi V et al (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117:76\u201381","journal-title":"Pediatrics"},{"key":"806_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/426456","volume":"191","author":"RD Bradford","year":"2005","unstructured":"Bradford RD, Cloud G, Lakeman AD et al (2005) Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis 191:227\u2013233","journal-title":"J Infect Dis"},{"key":"806_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1542\/peds.110.4.762","volume":"110","author":"LB Rivera","year":"2002","unstructured":"Rivera LB, Boppana SB, Fowler KB et al (2002) Predictor of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 110:762\u2013767","journal-title":"Pediatrics"},{"key":"806_CR24","unstructured":"Jones CA, Walker KS, Henderson-Smart DJ (2005) Antiviral therapy for symptomatic congenital cytomegalovirus infection in neonates and infants up to 3\u00a0months of age. The Cochrane Library Issue 1. Cochrane Collaboration, Wiley, New York, pp 1\u20136"},{"key":"806_CR25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/jac\/dkp083","volume":"63","author":"L Nassetta","year":"2009","unstructured":"Nassetta L, Kimberlin D, Whitley R (2009) Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother 63:862\u2013867","journal-title":"J Antimicrob Chemother"},{"key":"806_CR26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jp.7211854","volume":"28","author":"A Muller","year":"2008","unstructured":"Muller A, Eis-Hubinger AM, Brandhorst G et al (2008) Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol 28:74\u201376","journal-title":"J Perinatol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-009-0806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-009-0806-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-009-0806-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:34:15Z","timestamp":1559122455000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-009-0806-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,11]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s10096-009-0806-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,11]]}}}